Home › Compare › BYLTF vs ABBV
BYLTF yields 1031.46% · ABBV yields 3.06%● Live data
📍 BYLTF pulled ahead of the other in Year 1
Combined, BYLTF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BYLTF + ABBV for your $10,000?
Baylin Technologies Inc., together with its subsidiaries, researches, designs, develops, manufactures, and sells passive and active radio frequency (RF) products, satellite communications products, and supporting services. It offers embedded antennas for use in smartphones, tablets, and other mobile devices; device-specific antennas for Wi-Fi routers; gateway devices for smart home connectivity, set-top boxes, and land mobile radio products; and indoor and outdoor distributed antenna systems (DAS), small cell system antennas, and base station antennas (BSA) for original equipment manufacturer, DAS, BSA, and small cell markets. The company also provides RF components, including GaN-based power amplifiers, gallium arsenide-based power amplifiers, indoor and outdoor frequency converters, and transceivers; microwave components comprising point-to-point microwave radios and network management software; fixed and mobile antennas, and antenna controllers for customers in the broadcast, maritime and cruise ships, government and military, homeland security, direct-to-home satellite, oil and gas, and wireless communications verticals. In addition, it offers RF and microwave solid state power amplifiers; and pulsed amplifiers for radar applications, and transmitter and transceiver products, as well as RF passive components and systems. The company offers its products under the Galtronics, Advantech Wireless, Alga Microwave, and Mitec VSAT brands. It operates in the United States, Vietnam, China, India, Thailand, South Korea, Canada, Sweden, Indonesia, Hungary, Taiwan, Philippines, Portugal, Romania, Japan, Brazil, Israel, Singapore, Australia, France, Germany, Russia, and internationally. The company was founded in 1978 and is headquartered in Toronto, Canada.
Full BYLTF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.